(LCII) LCI Industries - Overview
Sector: Consumer CyclicalIndustry: Recreational Vehicles | Exchange NYSE (USA) | Currency USD | Market Cap: 2.843m | Total Return 42.9% in 12m
Stock: RV Parts, Trailer Parts, Boat Parts, Truck Accessories
Total Rating 66
Risk 84
Buy Signal -0.34
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -6.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.05 |
| Alpha | 25.41 |
| Character TTM | |
|---|---|
| Beta | 1.082 |
| Beta Downside | 1.851 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.12% |
| CAGR/Max DD | 0.23 |
EPS (Earnings per Share)
Revenue
Description: LCII LCI Industries March 05, 2026
LCI Industries manufactures and supplies engineered components for recreational vehicles (RVs) and related sectors. The company operates in two segments: Original Equipment Manufacturers (OEM) and Aftermarket.
The OEM segment provides a wide array of components directly to manufacturers of RVs, boats, and other specialty vehicles. This segments products include chassis, axles, braking systems, windows, doors, and various interior furnishings and appliances. The RV industry is cyclical, often tied to consumer discretionary spending.
The Aftermarket segment supplies components to retail dealers, wholesale distributors, service centers, and directly to consumers. This segment offers replacement parts, accessories, and upgrades, including glass, awnings, and various electronic and mechanical components. This segment can provide more stable revenue during economic downturns as consumers may opt to repair or upgrade existing vehicles rather than purchase new ones. To learn more about LCIIs financial performance, further research on ValueRay is recommended.
Headlines to watch out for
- RV production volumes dictate OEM segment revenue
- Raw material costs impact manufacturing profitability
- Interest rate hikes reduce consumer RV demand
- Aftermarket sales provide revenue diversification
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 188.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -2.57 > 1.0 |
| NWC/Revenue: 21.26% < 20% (prev 20.00%; Δ 1.26% < -1%) |
| CFO/TA 0.10 > 3% & CFO 331.0m > Net Income 188.2m |
| Net Debt (1.01b) to EBITDA (412.0m): 2.46 < 3 |
| Current Ratio: 2.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.3m) vs 12m ago -4.88% < -2% |
| Gross Margin: 23.78% > 18% (prev 0.24%; Δ 2.35k% > 0.5%) |
| Asset Turnover: 135.8% > 50% (prev 129.2%; Δ 6.56% > 0%) |
| Interest Coverage Ratio: 8.14 > 6 (EBITDA TTM 412.0m / Interest Expense TTM 35.7m) |
Altman Z'' 4.53
| A: 0.28 (Total Current Assets 1.35b - Total Current Liabilities 473.4m) / Total Assets 3.18b |
| B: 0.40 (Retained Earnings 1.28b / Total Assets 3.18b) |
| C: 0.10 (EBIT TTM 290.8m / Avg Total Assets 3.04b) |
| D: 0.73 (Book Value of Equity 1.32b / Total Liabilities 1.82b) |
| Altman-Z'' Score: 4.53 = AA |
Beneish M -2.95
| DSRI: 1.11 (Receivables 243.4m/199.6m, Revenue 4.12b/3.74b) |
| GMI: 0.99 (GM 23.78% / 23.51%) |
| AQI: 0.95 (AQ_t 0.35 / AQ_t-1 0.37) |
| SGI: 1.10 (Revenue 4.12b / 3.74b) |
| TATA: -0.04 (NI 188.2m - CFO 331.0m) / TA 3.18b) |
| Beneish M-Score: -2.95 (Cap -4..+1) = A |
What is the price of LCII shares?
As of March 26, 2026, the stock is trading at USD 122.92 with a total of 182,294 shares traded.
Over the past week, the price has changed by +1.31%, over one month by -8.88%, over three months by +0.30% and over the past year by +42.88%.
Over the past week, the price has changed by +1.31%, over one month by -8.88%, over three months by +0.30% and over the past year by +42.88%.
Is LCII a buy, sell or hold?
LCI Industries has received a consensus analysts rating of 3.44.
Therefor, it is recommend to hold LCII.
- StrongBuy: 2
- Buy: 1
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the LCII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 161.3 | 31.2% |
| Analysts Target Price | 161.3 | 31.2% |
LCII Fundamental Data Overview March 24, 2026
P/E Trailing = 15.5192
P/E Forward = 13.624
P/S = 0.6897
P/B = 2.0893
P/EG = 1.0389
Revenue TTM = 4.12b USD
EBIT TTM = 290.8m USD
EBITDA TTM = 412.0m USD
Long Term Debt = 941.5m USD (from longTermDebt, last quarter)
Short Term Debt = 47.9m USD (from shortTermDebt, last quarter)
Debt = 1.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.01b USD (from netDebt column, last quarter)
Enterprise Value = 3.86b USD (2.84b + Debt 1.24b - CCE 222.6m)
Interest Coverage Ratio = 8.14 (Ebit TTM 290.8m / Interest Expense TTM 35.7m)
EV/FCF = 13.85x (Enterprise Value 3.86b / FCF TTM 278.3m)
FCF Yield = 7.22% (FCF TTM 278.3m / Enterprise Value 3.86b)
FCF Margin = 6.75% (FCF TTM 278.3m / Revenue TTM 4.12b)
Net Margin = 4.57% (Net Income TTM 188.2m / Revenue TTM 4.12b)
Gross Margin = 23.78% ((Revenue TTM 4.12b - Cost of Revenue TTM 3.14b) / Revenue TTM)
Gross Margin QoQ = 22.08% (prev 24.37%)
Tobins Q-Ratio = 1.21 (Enterprise Value 3.86b / Total Assets 3.18b)
Interest Expense / Debt = 0.79% (Interest Expense 9.71m / Debt 1.24b)
Taxrate = 27.17% (6.97m / 25.7m)
NOPAT = 211.8m (EBIT 290.8m * (1 - 27.17%))
Current Ratio = 2.85 (Total Current Assets 1.35b / Total Current Liabilities 473.4m)
Debt / Equity = 0.91 (Debt 1.24b / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 2.46 (Net Debt 1.01b / EBITDA 412.0m)
Debt / FCF = 3.64 (Net Debt 1.01b / FCF TTM 278.3m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.20% (Net Income 188.2m / Total Assets 3.18b)
RoE = 13.76% (Net Income TTM 188.2m / Total Stockholder Equity 1.37b)
RoCE = 12.59% (EBIT 290.8m / Capital Employed (Equity 1.37b + L.T.Debt 941.5m))
RoIC = 9.15% (NOPAT 211.8m / Invested Capital 2.31b)
WACC = 7.00% (E(2.84b)/V(4.08b) * Re(9.79%) + D(1.24b)/V(4.08b) * Rd(0.79%) * (1-Tc(0.27)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.98%
[DCF] Terminal Value 80.97% ; FCFF base≈298.2m ; Y1≈269.5m ; Y5≈233.6m
[DCF] Fair Price = 177.1 (EV 5.30b - Net Debt 1.01b = Equity 4.29b / Shares 24.2m; r=7.00% [WACC]; 5y FCF grow -11.95% → 3.0% )
EPS Correlation: -18.50 | EPS CAGR: -48.18% | SUE: -0.05 | # QB: 0
Revenue Correlation: -50.17 | Revenue CAGR: -14.04% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.80 | Chg7d=+0.026 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=10
EPS current Year (2026-12-31): EPS=8.78 | Chg7d=+0.372 | Chg30d=+0.407 | Revisions Net=+9 | Growth EPS=+17.7% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=10.04 | Chg7d=-0.208 | Chg30d=-0.008 | Revisions Net=+2 | Growth EPS=+14.3% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +0.14 (4 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.8% - Earnings Yield 6.4%)
[Growth] Growth Spread = +0.7% (Analyst 4.1% - Implied 3.3%)
P/E Forward = 13.624
P/S = 0.6897
P/B = 2.0893
P/EG = 1.0389
Revenue TTM = 4.12b USD
EBIT TTM = 290.8m USD
EBITDA TTM = 412.0m USD
Long Term Debt = 941.5m USD (from longTermDebt, last quarter)
Short Term Debt = 47.9m USD (from shortTermDebt, last quarter)
Debt = 1.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.01b USD (from netDebt column, last quarter)
Enterprise Value = 3.86b USD (2.84b + Debt 1.24b - CCE 222.6m)
Interest Coverage Ratio = 8.14 (Ebit TTM 290.8m / Interest Expense TTM 35.7m)
EV/FCF = 13.85x (Enterprise Value 3.86b / FCF TTM 278.3m)
FCF Yield = 7.22% (FCF TTM 278.3m / Enterprise Value 3.86b)
FCF Margin = 6.75% (FCF TTM 278.3m / Revenue TTM 4.12b)
Net Margin = 4.57% (Net Income TTM 188.2m / Revenue TTM 4.12b)
Gross Margin = 23.78% ((Revenue TTM 4.12b - Cost of Revenue TTM 3.14b) / Revenue TTM)
Gross Margin QoQ = 22.08% (prev 24.37%)
Tobins Q-Ratio = 1.21 (Enterprise Value 3.86b / Total Assets 3.18b)
Interest Expense / Debt = 0.79% (Interest Expense 9.71m / Debt 1.24b)
Taxrate = 27.17% (6.97m / 25.7m)
NOPAT = 211.8m (EBIT 290.8m * (1 - 27.17%))
Current Ratio = 2.85 (Total Current Assets 1.35b / Total Current Liabilities 473.4m)
Debt / Equity = 0.91 (Debt 1.24b / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 2.46 (Net Debt 1.01b / EBITDA 412.0m)
Debt / FCF = 3.64 (Net Debt 1.01b / FCF TTM 278.3m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.20% (Net Income 188.2m / Total Assets 3.18b)
RoE = 13.76% (Net Income TTM 188.2m / Total Stockholder Equity 1.37b)
RoCE = 12.59% (EBIT 290.8m / Capital Employed (Equity 1.37b + L.T.Debt 941.5m))
RoIC = 9.15% (NOPAT 211.8m / Invested Capital 2.31b)
WACC = 7.00% (E(2.84b)/V(4.08b) * Re(9.79%) + D(1.24b)/V(4.08b) * Rd(0.79%) * (1-Tc(0.27)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.98%
[DCF] Terminal Value 80.97% ; FCFF base≈298.2m ; Y1≈269.5m ; Y5≈233.6m
[DCF] Fair Price = 177.1 (EV 5.30b - Net Debt 1.01b = Equity 4.29b / Shares 24.2m; r=7.00% [WACC]; 5y FCF grow -11.95% → 3.0% )
EPS Correlation: -18.50 | EPS CAGR: -48.18% | SUE: -0.05 | # QB: 0
Revenue Correlation: -50.17 | Revenue CAGR: -14.04% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.80 | Chg7d=+0.026 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=10
EPS current Year (2026-12-31): EPS=8.78 | Chg7d=+0.372 | Chg30d=+0.407 | Revisions Net=+9 | Growth EPS=+17.7% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=10.04 | Chg7d=-0.208 | Chg30d=-0.008 | Revisions Net=+2 | Growth EPS=+14.3% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +0.14 (4 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.8% - Earnings Yield 6.4%)
[Growth] Growth Spread = +0.7% (Analyst 4.1% - Implied 3.3%)